| Financial Year |
March 31 2023 |
| Monetary Funds |
1,732,054,000.98 |
| Held-for-trading Financial Assets |
186,274,866.67 |
| Notes Receivable |
-- |
| Accounts Receivable |
100,939,929.67 |
| Advances to Suppliers |
44,098,166.03 |
| Other Receivables |
65,971,331.35 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
191,181,985.61 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
9,415,904.60 |
| Total Current Assets |
2,339,080,575.64 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
4,995,182.43 |
| Investment Properties |
-- |
| Fixed Assetes |
5,833,772,041.45 |
| Under-construction Projects |
110,693,786.44 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
291,690,113.39 |
| R&D expenses |
25,777,076.48 |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
23,355,071.97 |
| Deferred Income Tax Assets |
-- |
| Other Non-Current Assets |
20,055,556.35 |
| Sub-Total of Non-Current Assets |
6,375,114,049.29 |
| Total Assets |
8,714,194,624.93 |
| Short-Term Loans |
2,103,850,573.69 |
| Trading Financial liabilities |
-- |
| Notes Payable |
171,653,256.13 |
| Accounts Payable |
287,668,039.59 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
36,637,190.75 |
| Taxes Payable |
8,032,658.12 |
| Interest Payable |
-- |
| Dividend Payable |
67,599,045.18 |
| Other payables |
152,238,292.19 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
612,086,884.35 |
| Other Current Liabilities |
39,387,312.28 |
| Sub-Total of Current Liabilities |
3,458,624,485.22 |
| Long-term Loans |
862,766,733.22 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
644,834,811.57 |
| Special Payable |
-- |
| Estimatied Liabilities |
8,309,849.19 |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,552,109,182.02 |
| Total Liabilities |
5,010,733,667.24 |
| Paid-In Capital(Or Share Stock) |
2,766,032,803.00 |
| Capital Surplus |
8,594,516,510.11 |
| Surplus Reserve |
579,982,557.57 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-8,251,279,087.87 |
| Minority Stockholder's Interest |
21,386,506.99 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,682,074,450.70 |
| Owner's Equity（Stockholder's Equity） |
3,703,460,957.69 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
8,714,194,624.93 |
